Allarity Therapeutics Inc (ALLR) Quote

Boston (May 14, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today reported financial results and provided an update on recent operational highlights for the first quarter that ended March 31, 2024.



“The start of 2024 has been a pivotal period for Allarity Therapeutics, marked by significant achievements across financial, regulatory, and clinical areas,” remarked Thomas Jensen, CEO of Allarity Therapeutics. “Our trials of stenoparib in advanced, recurrent ovarian cancer have yielded encouraging proof of concept data, which further boosted our optimism for the future of this novel PARP inhibitor. Additionally, we’ve seen several developments that we believe may strengthen our investment case. Our capital structure has been simplified, and we have raised new equity, so we are now on track to fully comply with Nasdaq’s listing requirements and find ourselves in a better position to steer clear of less favorable future financing arrangements. Reflecting this new strengthened financial position, we have requested the SEC to withdraw our Form S-1 filed last October. With a strategic focus now solely on stenoparib, we can use all our managerial resources to advance this promising asset toward regulatory approval.”

https://ih.advfn.com/stock-market/NASDAQ/allarity-therapeutics-ALLR/stock-news/93857171/form-8-k-current-report

Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved

- On Track to Regain Compliance with All Nasdaq Listing Requirements

- No Variable Priced Securities are Outstanding

Pure trash!! Just going to continue to sink!!

$ALLR more massive dilution from this scam how bullish.

Patience there's a nice bounce coming from .09 to 11

$ALLR atm will be off soon. We filed the Prior Prospectus to register the offer and sale of our common stock, par value $0.0001 per share, from time to time pursuant to the terms of that certain At-The-Market Issuance Sales Agreement (the “Sales Agreement”), between Ascendiant Capital Markets, LLC (the “Sales Agent”) and us. Prior to the date of this prospectus supplement, we were subject to General Instruction I.B.6 of Form S-3 as a result of our public float being less than $75.0 million, which limited the maximum amount of common stock we could sell under the Sales Agreement to the amount set forth in the Prior Prospectus (up to $18,000,000). On May 2, 2024, our public float increased above $75.0 million and, as a result, we are not subject to the limitations contained in General Instruction I.B.6 of Form S-3 as of the date of this prospectus supplement.



On May 6, 2024, we amended the Sales Agreement to, among other things, increase the total amount of common stock that we may offer and sell under the sales agreement to $20,000,000 (which amount includes shares we have already sold pursuant to the Sales Agreement prior to the date of this prospectus supplement), subject to certain limitations in the Sales Agreement, as amended. As of May 2, 2024, we have sold an aggregate of 10,835,422 shares of our common stock pursuant to the Sales Agreement for gross proceeds of 16,054,081 (the “Gross Proceeds”).

Trading at 4.5 cents on a pre rollback basis. Geez.

What a surprise
Will it grow legs after the reverse split

announced its intention to seek formal confirmation from Nasdaq regarding its compliance with the equity requirements outlined in Rule 5550(b)(1) of the exchange’s regulations. Currently its stockholders’ equity is significantly above the $2.5 million minimum required by Nasdaq Listing Rule 5550(b)(1).

Called it….right back under $1!! Just an absolute POS cluttering up the market!!

ALLR new 52 week low

https://stockcharts.com/h-sc/ui?s=allr&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/allr/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/allr/opinion

https://finance.yahoo.com/quote/allr/

ALLR worth a trade at this level!
$1.20

The information in this prospectus is not complete and may be changed. The selling stockholders named in this prospectus may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and the selling stockholders named in this prospectus are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.

Subject to completion, dated April 30, 2024

PROSPECTUS

Graphic

17,580,566 SHARES

COMMON STOCK

Shorts win again

No mercy for longs. Either from shorts or from management.

Nah it’s done and over. Closing red

More trash cluttering up the market! What a POS

lol looks like it’s gonna finish in the RED

What a piece of shit. Everyone got the news they were waiting for and this Terd couldn’t even hold $2

ALLR...POST SPLIT POP COMNG IN!!!!!

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

ALLR new 52 week low

You’re good at translating corporate speak
ALLR new 52 lo

ALLR new 52 lo

"In addition, the company has entered into negotiations with key stakeholders, including warrant holders, to adjust the terms and conditions to make future capital raising more amenable, as well as negotiations to reduce other major liabilities. Finally, the Company has already started raising new equity by utilizing its existing ATM and expects to take further action so Allarity can meet the $2,500,000 equity requirement on the May 14, 2024 target date."

They plan on CONTINUING TO DUMP SHARES on the open market and DILUTING their shareholders with no end in sight.

"Our goal is to ensure that we can continue our development of stenoparib, strongly encouraged by the significant early data we have received so far from our ongoing monotherapy trial in advanced ovarian cancer."

In other words stenoparib is still not ready for phase 3. They are going to have to chemically modify it to try to improve it which means repeating phase 1 and phase 2 trials. They are going to need a A LOT more time and money and there is no guarantee at all that they can get it modified to the point it needs to be at.

This is a TOXIC investment. If there happens to be a pump, sell for what you can and get out. They are just going to continue with the reverse splits followed by dilution for the foreseeable future as they have no revenue, no product, and thomas jackass jensen needs to collect his handsome salary.

Good call imo. I was just surfing around Monks new 52 wk low calls. There's usually a good reason for that. Multiple RS's and offerings at the wrong time.

GL

Most pharmaceutical R&D companies are high risk poorly run trash investments. Even by those standards ALLR is relative garbage. This is literally a bottom of the barrel company running purely off of lies and deceit by management. I’ve been investing for 15 years and have never see a company destroy their investors this aggressively and this quickly. Despite diluting us into oblivion, the market cap is again under $1 million as of today. Stenoparib clinical data is obviously showing that it is either not safe or not effective, otherwise this would not be happening. ALLR is DONE. Do NOT invest.

Nothing to be bullish about here. This company is now a one trick pony. If stenoparib fails they are done. I'm thinking if stenoparib was doing as good as their last press release indicated then the price would be appreciating. Tread carefully as investing in this company is a gamble and I personally do not trust management.

New blood soaking up the float, is only a matter of time before we roar

Dirty short rats are going to get it up the ass power hour and TGIF

wrong answer as usual!!! Here come the Pharma bulls!!

Precious metals have the MOJO at present

The dip is in dude!! Let’s see if this baby has power!!!

FDA Green light will send this flying in outer space

No kidding!!! HiUge Short squeeze is imminent All holding for lift -off

ALLR no 1 on the Barchart 100

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

Hit it 200k float

ALLR new 52 lo

down 13% today , expecting lower

DOWN 3% TODAY, EXPECTING LOWER

Trading Halt at 7:50 pm wonder if it has anything to do with the R/S

Rs april 9 th 1/20

ALLR new 52 lo

Why ?

Buy and hold,period

Picking up the dips

ALLR new 52 week low

ALLR new 52 week low

ALLR: Any time, Dude!!

PS: If I myself were running the USA, every 'Women' over 16 would be REQUIRED & AUTHORIZED to pack-a-firearm --- concealed, or otherwise --- and THEN see if America's MEN would still MESS with them!!! I.e., not merely regarding Wall Street STOCK issues regarding Women.

Thanks for the feedback